1-(4-(4-Amino-7-(3-morpholinopropyl)-7H-pyrrolo[2,3-d]-pyrimidin-5-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea

ID: ALA4572804

PubChem CID: 155563426

Max Phase: Preclinical

Molecular Formula: C27H34N8O3

Molecular Weight: 518.62

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(CCCN4CCOCC4)c4ncnc(N)c34)cc2)no1

Standard InChI:  InChI=1S/C27H34N8O3/c1-27(2,3)21-15-22(33-38-21)32-26(36)31-19-7-5-18(6-8-19)20-16-35(25-23(20)24(28)29-17-30-25)10-4-9-34-11-13-37-14-12-34/h5-8,15-17H,4,9-14H2,1-3H3,(H2,28,29,30)(H2,31,32,33,36)

Standard InChI Key:  DFFNBUFTNUREFC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   19.5444  -12.4631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2501  -12.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2460  -13.6924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9598  -12.4702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9518  -13.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4092  -14.3999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4080  -15.2194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1161  -15.6284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1143  -13.9910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8229  -14.3963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8277  -15.2149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6077  -15.4633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0851  -14.7982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6000  -14.1388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1118  -13.1738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0205  -16.1685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8377  -16.1643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0132  -13.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8310  -13.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2449  -12.7420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8416  -12.0302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0201  -12.0267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6100  -12.7311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2545  -11.3251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0717  -11.3301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4847  -10.6250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.4759  -12.0403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2931  -12.0454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7657  -12.7108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5495  -11.6458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7739  -11.3886    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2499  -16.8699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8450  -17.5797    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0289  -17.5813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6240  -18.2871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0328  -18.9951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8510  -18.9928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2603  -18.2826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  6  7  2  0
  7  8  1  0
  8 11  2  0
 10  9  2  0
  9  6  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  9 15  1  0
 12 16  1  0
 16 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29  1  2  0
  1 30  1  0
 30 31  1  0
 31 28  2  0
 17 32  1  0
 32 33  1  0
 33 34  1  0
 33 38  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4572804

    ---

Associated Targets(Human)

MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RS4-11 (1012 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.62Molecular Weight (Monoisotopic): 518.2754AlogP: 4.33#Rotatable Bonds: 7
Polar Surface Area: 136.36Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.27CX Basic pKa: 7.78CX LogP: 3.19CX LogD: 2.96
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.59

References

1. Yuan X, Chen Y, Zhang W, He J, Lei L, Tang M, Liu J, Li M, Dou C, Yang T, Yang L, Yang S, Wei Y, Peng A, Niu T, Xiang M, Ye H, Chen L..  (2019)  Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.,  62  (8): [PMID:30939008] [10.1021/acs.jmedchem.9b00223]

Source